New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
RA linked to restrictive, obstructive spirometry patterns

RA linked to restrictive, obstructive spirometry patterns

(HealthDay)—Rheumatoid arthritis (RA) is associated with restrictive and obstructive spirometry patterns, with the strongest associations seen for severe patterns, according to a study published onlin
Immunology & Rheumatology June 01,2024
RA linked to restrictive, obstructive spirometry patterns

RA linked to restrictive, obstructive spirometry patterns

(HealthDay)—Rheumatoid arthritis (RA) is associated with restrictive and obstructive spirometry patterns, with the strongest associations seen for severe patterns, according to a study published onlin
Immunology & Rheumatology June 01,2024
Poverty tied to worse functional status in rheumatoid arthritis

Poverty tied to worse functional status in rheumatoid arthritis

(HealthDay)—Worse functional status and increased probability of functional decline are seen for patients with rheumatoid arthritis (RA) with lower socioeconomic status (SES), according to a study pub
Immunology & Rheumatology June 01,2024
Poverty tied to worse functional status in rheumatoid arthritis

Poverty tied to worse functional status in rheumatoid arthritis

(HealthDay)—Worse functional status and increased probability of functional decline are seen for patients with rheumatoid arthritis (RA) with lower socioeconomic status (SES), according to a study pub
Immunology & Rheumatology June 01,2024
Air pollution linked to increased rheumatoid arthritis severity

Air pollution linked to increased rheumatoid arthritis severity

(HealthDay)—Air pollution is associated with increased rheumatoid arthritis (RA) disease severity, according to a study published in the October issue ofRheumatology.Giovanni Adami, M.D., Ph.D.,
Immunology & Rheumatology June 01,2024
Air pollution linked to increased rheumatoid arthritis severity

Air pollution linked to increased rheumatoid arthritis severity

(HealthDay)—Air pollution is associated with increased rheumatoid arthritis (RA) disease severity, according to a study published in the October issue ofRheumatology.Giovanni Adami, M.D., Ph.D.,
Immunology & Rheumatology June 01,2024
High BMI elevates risk of several rheumatic diseases, but not equally for everyone

High BMI elevates risk of several rheumatic diseases, but not equally for everyone

by Uppsala UniversityCredit: Pixabay/CC0 Public DomainA new study by Uppsala University shows that a higher body mass index (BMI) increases the risk of five different rheumatic diseases: rheumati
Immunology & Rheumatology June 01,2024
High BMI elevates risk of several rheumatic diseases, but not equally for everyone

High BMI elevates risk of several rheumatic diseases, but not equally for everyone

by Uppsala UniversityCredit: Pixabay/CC0 Public DomainA new study by Uppsala University shows that a higher body mass index (BMI) increases the risk of five different rheumatic diseases: rheumati
Immunology & Rheumatology June 01,2024
Researchers urge arthritis patients to give up smoking to help them live longer

Researchers urge arthritis patients to give up smoking to help them live longer

by University of ManchesterCredit: Artem Podrez from PexelsUniversity of Manchester-led research has found new evidence to suggest that, not only is smoking associated with earlier deaths i
Immunology & Rheumatology June 01,2024
Researchers urge arthritis patients to give up smoking to help them live longer

Researchers urge arthritis patients to give up smoking to help them live longer

by University of ManchesterCredit: Artem Podrez from PexelsUniversity of Manchester-led research has found new evidence to suggest that, not only is smoking associated with earlier deaths i
Immunology & Rheumatology June 01,2024
Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in
Immunology & Rheumatology June 01,2024
Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in
Immunology & Rheumatology June 01,2024
Women with rheumatoid arthritis more likely to achieve remission if they take sex hormones, finds research

Women with rheumatoid arthritis more likely to achieve remission if they take sex hormones, finds research

by University of South AustraliaGraphical abstract. Credit:Rheumatology(2022). DOI: 10.1093/rheumatology/keac357A large study of women with rheumatoid arthritis has found that those t
Immunology & Rheumatology June 01,2024
Women with rheumatoid arthritis more likely to achieve remission if they take sex hormones, finds research

Women with rheumatoid arthritis more likely to achieve remission if they take sex hormones, finds research

by University of South AustraliaGraphical abstract. Credit:Rheumatology(2022). DOI: 10.1093/rheumatology/keac357A large study of women with rheumatoid arthritis has found that those t
Immunology & Rheumatology June 01,2024
CVD risk factors tied to disease activity, disability in RA

CVD risk factors tied to disease activity, disability in RA

(HealthDay)—Cardiovascular disease (CVD) risk factors alone, or in combination, are associated with higher disease activity and disability in rheumatoid arthritis (RA), according to a study recently p
Immunology & Rheumatology June 01,2024
CVD risk factors tied to disease activity, disability in RA

CVD risk factors tied to disease activity, disability in RA

(HealthDay)—Cardiovascular disease (CVD) risk factors alone, or in combination, are associated with higher disease activity and disability in rheumatoid arthritis (RA), according to a study recently p
Immunology & Rheumatology June 01,2024
Higher body temperatures still a factor in patients in remission from rheumatoid arthritis

Higher body temperatures still a factor in patients in remission from rheumatoid arthritis

by Staffordshire UniversityThermal image showing temperatures in the different regions of the foot. Credit: Staffordshire UniversityA pioneering study carried out among patients in remission from Rheu
Immunology & Rheumatology June 01,2024
Higher body temperatures still a factor in patients in remission from rheumatoid arthritis

Higher body temperatures still a factor in patients in remission from rheumatoid arthritis

by Staffordshire UniversityThermal image showing temperatures in the different regions of the foot. Credit: Staffordshire UniversityA pioneering study carried out among patients in remission from Rheu
Immunology & Rheumatology June 01,2024
Risankizumab safe, effective at 52 weeks for psoriatic arthritis

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe
Immunology & Rheumatology June 01,2024
Risankizumab safe, effective at 52 weeks for psoriatic arthritis

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe
Immunology & Rheumatology June 01,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com